Register
Register
Register

Thursday, 22 May 2025 | 15:05 - 15:20

From Vein to Vaccine: dendritic cell vaccination for pediatric patients with high-grade glioma and diffuse intrinsic pontine glioma - Toon Van Genechten, University Hospital Antwerp

Format:In-person

Background of a phase I/II clinical trial assessing the safety and feasibility of implementing Wilms Tumor 1 mRNA electroporated directed dendritic cell immunotherapy in a paediatric cohort of patients with high-grade glioma and diffuse intrinsic pontine glioma.

1 speaker

  • Toon Van Genechten

    Senior staff member Pediatric hemato-oncologist, Phd student university (hospital) Antwerp

    Antwerp University Hospital